Jonathan M. Gerber

Chief of Hematology/Oncology, Medical Director of the Cancer Center, and Eleanor Eustis Farrington Chair in Cancer Research, University of Massachusetts Medical School

Jonathan Gerber's research focuses on improving the identification and targeting of stem cells at the root of leukemia and related diseases, with the goal of personalizing therapy and developing better treatments that are more effective and less toxic. The assay that he developed to detect leukemia stem cells was granted a U.S. patent in 2015, and it has since been advanced into a clinical trial.

Experience

  • –present
    Professor of Medicine and Section Chief, Hematology and Oncology, University of Massachusetts Medical School